Nutritional support and immunonutrition in esophageal cancer – From perioperative care to long-term survivorship: A review
DOI:
https://doi.org/10.17305/bb.2025.13328Keywords:
Esophageal cancer, nutritional therapy, immuno-nutrition, enteral nutrition, parenteral nutrition, prehabilitation, precision nutrition, quality of life, oncological careAbstract
Esophageal cancer is recognized as one of the most aggressive malignancies within the digestive system, with global survival rates typically falling below 20%. Malnutrition impacts up to 80% of patients, significantly affecting treatment tolerance, postoperative outcomes, and overall quality of life. Recent advancements in clinical nutrition and immunometabolism have transformed the perception of nutrition from a mere supportive measure to a vital therapeutic component in cancer care. This review synthesizes evidence from studies published between 2010 and 2025, exploring the effects of various nutritional strategies—including enteral, elemental, parenteral, immuno-nutritional, behavioral, and prehabilitative interventions—on metabolism, immune response, and clinical outcomes in patients with esophageal cancer. The findings demonstrate that targeted approaches such as immune-enhancing enteral formulations, omega-3-enriched parenteral nutrition, and structured dietary counseling can mitigate inflammation, preserve muscle mass, enhance treatment adherence, and improve psychological well-being. Overall, the literature supports the perspective of nutrition as a precision-based, integral component of multidisciplinary cancer management. Incorporating nutritional optimization throughout all stages of care—ranging from prehabilitation and perioperative support to survivorship and palliative management—can enhance metabolic resilience, promote faster recovery, and significantly improve the quality of life for individuals diagnosed with esophageal cancer.
Citations
Downloads
References
Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, et al. The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020. Gastroenterology. 2022;163(3):649-658.e2. doi: https://doi.org/10.1053/j.gastro.2022.05.054
Prado CM, Purcell SA, Laviano A. Nutrition interventions to treat low muscle mass in cancer. J Cachexia Sarcopenia Muscle. 2020;11(2):366-380. doi: https://doi.org/10.1002/jcsm.12525
Ma X, Pei B, Wu N, Wang C, Yu Y, Yang W. Current research and future prospects of immunonutrition in gastrointestinal malignancies. Front Immunol. 2024;15:1420415. doi: https://doi.org/10.3389/fimmu.2024.1420415
Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489-495. doi: https://doi.org/10.1016/S1470-2045(10)70218-7
Xin C, Wang Y, Luo Y, Gai Y, Han B. Effect of perioperative immunonutrition on outcomes in gastric cancer surgery patients: A systematic review and evidence map. Clin Nutr ESPEN. 2025;67:90-104. doi: https://doi.org/10.1016/j.clnesp.2025.02.029
Qiu Y, You J, Wang K, Cao Y, Hu Y, Zhang H, et al. Effect of whole-course nutrition management on patients with esophageal cancer undergoing concurrent chemoradiotherapy: A randomized control trial. Nutrition. 2020;69:110558. doi: https://doi.org/10.1016/j.nut.2019.110558
Lyu J, Shi A, Li T, Li J, Zhao R, Zhu S, et al. Effects of Enteral Nutrition on Patients With Oesophageal Carcinoma Treated With Concurrent Chemoradiotherapy: A Prospective, Multicentre, Randomised, Controlled Study. Front Oncol. 2022;12:839516. doi: https://doi.org/10.3389/fonc.2022.839516
Pinto E, Nardi MT, Marchi R, Cavallin F, Alfieri R, Saadeh L, et al. QOLEC2: a randomized controlled trial on nutritional and respiratory counseling after esophagectomy for cancer. Support Care Cancer. 2021;29(2):1025-1033. doi: https://doi.org/10.1007/s00520-020-05573-z
Cao Y, Han D, Yang S, Shi Y, Zhao S, Jin Q, et al. Effects of pre-operative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy: Protocol for a multicenter randomized controlled trial (POINT trial, pre-operative immunonutrition therapy). BMC Cancer. 2022;22(1):650. doi: https://doi.org/10.1186/s12885-022-09721-y
Li XK, Cong ZZ, Wu WJ, Xu Y, Zhou H, Wang GM, et al. Enteral immunonutrition versus enteral nutrition for patients undergoing esophagectomy: a randomized controlled trial. Ann Palliat Med. 2021;10(2):1351-1361. doi: https://doi.org/10.21037/apm-20-1399
Lin YC, Pimiento JM, Milano J, Riccardi D, McKinnie N, Hume E, et al. Feasibility trial of STRONG: A digital intervention to improve nutritional management for individuals with esophageal and gastroesophageal junction cancer. Contemp Clin Trials Commun. 2025;43:101421. doi: https://doi.org/10.1016/j.conctc.2024.101421
Siemińska I, Lenart M. Immunometabolism of Innate Immune Cells in Gastrointestinal Cancer. Cancers (Basel). 2025;17(9):1467. doi: https://doi.org/10.3390/cancers17091467
Vasson MP, Talvas J, Perche O, Dillies AF, Bachmann P, Pezet D, et al. Immunonutrition improves functional capacities in head and neck and esophageal cancer patients undergoing radiochemotherapy: A randomized clinical trial. Clin Nutr. 2014;33(2):204-210. doi: https://doi.org/10.1016/j.clnu.2013.06.008
St-Pierre J, Coca-Martinez M, Drummond K, Minnella E, Ramanakumar AV, Ferri L, et al. Multimodal prehabilitation to enhance functional capacity of patients with esophageal cancer during concurrent neoadjuvant chemotherapies: A randomized feasibility trial. Dis Esophagus. 2024;37(12):doae087. doi: https://doi.org/10.1093/dote/doae087
Chen X, Zhong L, Wang J, Dai T, Li M, Luo J, et al. Multimodal rehabilitation to improve quality of life and fatigue after radiotherapy in esophageal cancer patients: a randomized trial. Oncologist. 2025;30(6):oyaf073. doi: https://doi.org/10.1093/oncolo/oyaf073
Pinto E, Nardi MT, Marchi R, Cavallin F, Alfieri R, Saadeh L, Cagol M, Baldan I, Saraceni E, Parotto M, Baratto F, Caberlotto C, Vianello A, Castoro C, Scarpa M. QOLEC2: a randomized controlled trial on nutritional and respiratory counseling after esophagectomy for cancer. Support Care Cancer. 2021 Feb;29(2):1025-1033. doi: https://doi.org/10.1007/s00520-020-05573-z. Epub 2020 Jun 22. PMID: 32572611; PMCID: PMC7307937.
Poulsen GM, Pedersen LL, Østerlind K, Bæksgaard L, Andersen JR. Randomized trial of the effects of individual nutritional counseling in cancer patients. Clin Nutr. 2014;33(5):749-753. doi: https://doi.org/10.1016/j.clnu.2013.10.019
Terayama M, Imamura Y, Kitazawa T, Miyazaki N, Ishii M, Takagi K, et al. The effect of a low-carbohydrate enteral nutrition formula on postoperative hyperglycemia in non-diabetic patients with esophageal cancer: A randomized exploratory phase II trial (ENLICHE study). PLoS One. 2025;20(5):e0325039. doi: https://doi.org/10.1371/journal.pone.0325039
Vasson MP, Talvas J, Perche O, Dillies AF, Bachmann P, Pezet D, Achim AC, Pommier P, Racadot S, Weber A, Ramdani M, Kwiatkowski F, Bouteloup C. Immunonutrition improves functional capacities in head and neck and esophageal cancer patients undergoing radiochemotherapy: a randomized clinical trial. Clin Nutr. 2014 Apr;33(2):204-10. doi: https://doi.org/10.1016/j.clnu.2013.06.008. Epub 2013 Jun 20. PMID: 23849811.
Kitagawa H, Namikawa T, Yatabe T, Munekage M, Yamasaki F, Kobayashi M, et al. Effects of a preoperative immune-modulating diet in patients with esophageal cancer: a prospective parallel group randomized study. Langenbecks Arch Surg. 2017;402(3):531-538. doi: https://doi.org/10.1007/s00423-016-1538-5
Chitapanarux I, Traisathit P, Chitapanarux T, Jiratrachu R, Chottaweesak P, Chakrabandhu S, et al. Arginine, glutamine, and fish oil supplementation in cancer patients treated with concurrent chemoradiotherapy: A randomized control study. Curr Probl Cancer. 2020;44(1):100482. doi: https://doi.org/10.1016/j.currproblcancer.2019.05.005
Long H, Yang H, Lin Y, Situ D, Liu W. Fish Oil-Supplemented Parenteral Nutrition in Patients Following Esophageal Cancer Surgery: Effect on Inflammation and Immune Function. Nutr Cancer. 2013;65(1):71-75. doi: https://doi.org/10.1080/01635581.2013.741761
Katada C, Fukazawa S, Sugawara M, Sakamoto Y, Takahashi K, Takahashi A, et al. Randomized study of prevention of gastrointestinal toxicities by nutritional support using an amino acid-rich elemental diet during chemotherapy in patients with esophageal cancer (KDOG 1101). Esophagus. 2021;18(2):296-305. doi: https://doi.org/10.1007/s10388-020-00787-w
Tanaka Y, Takahashi T, Yamaguchi K, Osada S, Shimokawa T, Yoshida K. Elemental diet plus glutamine for the prevention of mucositis in esophageal cancer patients receiving chemotherapy: a feasibility study. Support Care Cancer. 2016;24(2):933-941. doi: https://doi.org/10.1007/s00520-015-2864-9
Tanaka Y, Takahashi T, Yamaguchi K, Osada S, Shimokawa T, Yoshida K. Erratum to: Elemental diet plus glutamine for the prevention of mucositis in esophageal cancer patients receiving chemotherapy: a feasibility study. Support Care Cancer. 2016;24(2):943. doi: https://doi.org/10.1007/s00520-015-3003-3
Ishikawa T, Yasuda T, Doi T, Okayama T, Sakamoto N, Gen Y, et al. The amino acid-rich elemental diet Elental® preserves lean body mass during chemo- or chemoradiotherapy for esophageal cancer. Oncol Rep. 2016;36(2):1093-1100. doi: https://doi.org/10.3892/or.2016.4877
St-Pierre J, Coca-Martinez M, Drummond K, Minnella E, Ramanakumar AV, Ferri L, Carli F, Scheede-Bergdahl C. Multimodal prehabilitation to enhance functional capacity of patients with esophageal cancer during concurrent neoadjuvant chemotherapies-a randomized feasibility trial. Dis Esophagus. 2024 Nov 28;37(12):doae087. doi: https://doi.org/10.1093/dote/doae087. PMID: 39377252; PMCID: PMC11605552.
Chen HM, Huang CS, Wu YC, Chien LI, Hsu PK. The effects of a 3-month walking and dietary education program on the quality of life of patients with esophageal cancer: a 1-year follow-up randomized controlled trial. Support Care Cancer. 2025;33(5):441. doi: https://doi.org/10.1007/s00520-025-09489-4
Fietkau R, Lewitzki V, Kuhnt T, Hölscher T, Hess C, Berger B, et al. A disease-specific enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: Results of a randomized, controlled, multicenter trial. Cancer. 2013;119(18):3343-3353. doi: https://doi.org/10.1002/cncr.28197
Aiko S, Kumano I, Yamanaka N, Tsujimoto H, Takahata R, Maehara T. Effects of an immuno-enhanced diet containing antioxidants in esophageal cancer surgery following neoadjuvant therapy: Effects of antioxidants-containing IED. Dis Esophagus. 2012;25(2):137-145. doi: https://doi.org/10.1111/j.1442-2050.2011.01221.x
Markar S, Mariette C, Bonnetain F, Lundell L, Rosati R, de Manzoni G, et al. Immunonutrition to improve the quality of life of upper gastrointestinal cancer patients undergoing neoadjuvant treatment prior to surgery (NEOIMMUNE): double-blind randomized controlled multicenter clinical trial. Dis Esophagus. 2025;38(1):doae113. doi: https://doi.org/10.1093/dote/doae113
Wang SM, Taylor PR, Fan JH, Pfeiffer RM, Gail MH, Liang H, et al. Effects of Nutrition Intervention on Total and Cancer Mortality: 25-Year Post-trial Follow-up of the 5.25-Year Linxian Nutrition Intervention Trial. JNCI J Natl Cancer Inst. 2018;110(11):1229-1238. doi: https://doi.org/10.1093/jnci/djy043
Peng J, Cai J, Niu ZX, Chen LQ. Early enteral nutrition compared with parenteral nutrition for esophageal cancer patients after esophagectomy: a meta-analysis: Early EN versus PN after esophagectomy. Dis Esophagus. 2016;29(4):333-341. doi: https://doi.org/10.1111/dote.12337
Weijs TJ, Berkelmans GH, Nieuwenhuijzen GA, Dolmans AC, Kouwenhoven EA, Rosman C, Ruurda JP, van Workum F, van Det MJ, Silva Corten LC, van Hillegersberg R, Luyer MD. Immediate postoperative oral nutrition following esophagectomy: a multicenter clinical trial. Ann Thorac Surg. 2016 Oct;102(4):1141-8. doi: https://doi.org/10.1016/j.athoracsur.2016.04.067. Epub 2016 Jun 17. PMID: 27324526.
Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, et al. ESPEN practical guideline: Clinical Nutrition in cancer. Clin Nutr. 2021;40(5):2898-2913. doi: https://doi.org/10.1016/j.clnu.2021.02.005
Liu L, Wang YC, Liu QW, Zhong JD, Li JB, Wu XD, et al. Home enteral nutrition after esophagectomy for esophageal cancer: A systematic review and meta-analysis. Medicine (Baltimore). 2020;99(36):e21988. doi: https://doi.org/10.1097/MD.0000000000021988
Zhang C, Hu LW, Qiang Y, Cong ZZ, Zheng C, Gu WF, et al. Home enteral nutrition for patients with esophageal cancer undergoing esophagectomy: A systematic review and meta-analysis. Front Nutr. 2022;9:895422. doi: https://doi.org/10.3389/fnut.2022.895422
Kimura Y, Gakuhara A, Fukuda S, Fukuda Y, Yoshihara T, Koga C, et al. Nutritional management during chemotherapy and chemoradiotherapy for advanced esophageal cancer. Esophagus. 2025;22(3):279-288. doi: https://doi.org/10.1007/s10388-025-01117-8
McIsaac DI, Kidd G, Gillis C, Branje K, Al-Bayati M, Baxi A, et al. Relative efficacy of prehabilitation interventions and their components: systematic review with network and component network meta-analyses of randomised controlled trials. BMJ. 2025;388:e081164. doi: https://doi.org/10.1136/bmj-2024-081164
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2025 Mohamed Hussein, Tayfor Mohamed, Fatma Abdulla Mubarak, Fatmah Morad, Maryam Naser, Ayesha Humaira, Haala Amina, Manal Khan

This work is licensed under a Creative Commons Attribution 4.0 International License.




